OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The multifaceted antineoplastic role of pyrimethamine against human malignancies
Shanaya Ramchandani, Chakrabhavi Dhananjaya Mohan, Jenaifer Rustom Mistry, et al.
IUBMB Life (2021) Vol. 74, Iss. 3, pp. 198-212
Closed Access | Times Cited: 12
Shanaya Ramchandani, Chakrabhavi Dhananjaya Mohan, Jenaifer Rustom Mistry, et al.
IUBMB Life (2021) Vol. 74, Iss. 3, pp. 198-212
Closed Access | Times Cited: 12
Showing 12 citing articles:
Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds
Ragi Jadimurthy, Shilpa Borehalli Mayegowda, S. Chandra Nayak, et al.
Biotechnology Reports (2022) Vol. 34, pp. e00728-e00728
Open Access | Times Cited: 51
Ragi Jadimurthy, Shilpa Borehalli Mayegowda, S. Chandra Nayak, et al.
Biotechnology Reports (2022) Vol. 34, pp. e00728-e00728
Open Access | Times Cited: 51
3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma
Chakrabhavi Dhananjaya Mohan, Min Yang, Shobith Rangappa, et al.
Biology (2021) Vol. 11, Iss. 1, pp. 29-29
Open Access | Times Cited: 22
Chakrabhavi Dhananjaya Mohan, Min Yang, Shobith Rangappa, et al.
Biology (2021) Vol. 11, Iss. 1, pp. 29-29
Open Access | Times Cited: 22
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 12
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 12
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Richard E. Kast
Oncoscience (2024) Vol. 11, pp. 15-31
Open Access | Times Cited: 1
Richard E. Kast
Oncoscience (2024) Vol. 11, pp. 15-31
Open Access | Times Cited: 1
Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens
Jennifer I. Brown, Rosanne Persaud, Petar Iliev, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115971-115971
Closed Access | Times Cited: 3
Jennifer I. Brown, Rosanne Persaud, Petar Iliev, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115971-115971
Closed Access | Times Cited: 3
Pyrimethamine reduced tumour growth in pre-clinical cancer models: a systematic review to identify potential pre-clinical studies for subsequent human clinical trials
Sivananthan Manoharan, Lee Ying Ying
Biology Methods and Protocols (2024) Vol. 9, Iss. 1
Open Access
Sivananthan Manoharan, Lee Ying Ying
Biology Methods and Protocols (2024) Vol. 9, Iss. 1
Open Access
Dihydrofolate Reductase Inhibitors as Anticancer Agents: Progress and Perspectives in Drug Design and Development
Dickson Kong, Anton V. Dolzhenko
Interdisciplinary cancer research (2024)
Closed Access
Dickson Kong, Anton V. Dolzhenko
Interdisciplinary cancer research (2024)
Closed Access
PKM2 Confers Purine Metabolic Advantage and Enhances Lenvatinib Resistance in Hepatocellular Carcinoma
Lei Chen, Peng Wang, Hongyang Wang, et al.
Research Square (Research Square) (2023)
Open Access
Lei Chen, Peng Wang, Hongyang Wang, et al.
Research Square (Research Square) (2023)
Open Access
Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes
Hao Ding, Yuanyuan Teng, Ping Gao, et al.
Human Molecular Genetics (2023)
Closed Access
Hao Ding, Yuanyuan Teng, Ping Gao, et al.
Human Molecular Genetics (2023)
Closed Access
Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
Jia-Hao Zheng, Hong-Fei Yao, ZongâHao Duan, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1336-1336
Open Access
Jia-Hao Zheng, Hong-Fei Yao, ZongâHao Duan, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1336-1336
Open Access
